Coragen eVo leverages a highly concentrated formulation of Rynaxypyr active for long-lasting, fast-acting protection against ...

FMC stock fell 70%, but recovery potential exists with new products, sustainability focus, ... New formulations and tank-mix compatibility are currently driving adoption, ...

For 2025, FMC projects revenue of between $4.15 billion and $4.35 billion and adjusted EPS of between $3.26 and $3.70, which in both cases implies little improvement from last year.